ID: ALA3930364

Max Phase: Preclinical

Molecular Formula: C25H29N3OS

Molecular Weight: 419.59

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C1CCc2ccccc2N1CCCCN1CCN(c2cccc3sccc23)CC1

Standard InChI:  InChI=1S/C25H29N3OS/c29-25-11-10-20-6-1-2-7-22(20)28(25)14-4-3-13-26-15-17-27(18-16-26)23-8-5-9-24-21(23)12-19-30-24/h1-2,5-9,12,19H,3-4,10-11,13-18H2

Standard InChI Key:  YFZQHYRTAYCBIY-UHFFFAOYSA-N

Associated Targets(non-human)

Serotonin 2a (5-HT2a) receptor 3540 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 419.59Molecular Weight (Monoisotopic): 419.2031AlogP: 4.78#Rotatable Bonds: 6
Polar Surface Area: 26.79Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 8.19CX LogP: 4.59CX LogD: 3.73
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.54Np Likeness Score: -1.58

References

1.  (2015)  Piperazine-substituted benzothiophenes for treatment of mental disorders, 

Source

Source(1):